Global Hemoglobin A1c Monitoring Market to Cross US$1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Hemoglobin A1c Monitoring Market. The world market for Hemoglobin A1c Monitoring is projected to exceed US $1.6 billion by the year 2015. The market is primarily driven by the growing number of people diagnosed with diabetes mellitus, across the world. Other factors such as greater glucose control, product innovations that help improve compliance or convenience, are driving the market.

Hemoglobin A1c Monitoring: A Global Strategic Business report

As per the International Diabetes Federation (IDF), an estimated 285 million people, across the globe, are affected by diabetes mellitus, of which less than half have been identified. The seriousness of the affliction and the need for effective therapy to manage diabetes has led to the emergence of a significant market for monitoring the treatment efficiency of the disease. A1c monitoring is the standard practice adopted for monitoring diabetes to facilitate better diabetes management. The test is done before starting treatment for patients diagnosed with type 1 or type 2diabetes mellitus.

Diabetes patients (type I) who regularly monitor their HbA1c (hemoglobin A1c) levels could attain tight glucose control, thus considerably reducing their vulnerability to a cardiovascular disease. High blood sugar level for a longer period of time could result in increasing the risk of heart disease or stroke. An HbA1c level more that 4.6 indicates the person is at increased risk for heart attack.

The US dominates the global Hemoglobin A1c Monitoring market as stated by the new market research report on hemoglobin A1c monitoring market. Deaths on account of diabetes and its associated complications in the US total an estimated 150,000 annually. Type 2 diabetes occurs most often among African Americans, Asian and Pacific Islander Americans, American Indians, and Hispanic Americans. Diabetes risk among non-Hispanic African Americans is two times higher when compared to non-Hispanic whites of the same age. Similarly, diabetes risk among Hispanic Americans is nearly twofold when compared to non-Hispanic whites.

Key players profiled in the report include Abbott Laboratories, Axis-Shield Plc, Bayer Healthcare Diabetes Care, Beckman Coulter, Inc., Bio-Rad Laboratories Inc., Primus Diagnostics, Roche Diagnostics, Seradyn, Inc., and Tosoh Bioscience, Inc., among others.

The report titled "Hemoglobin A1c Monitoring: A Global Strategic Business report" announced by Global Industry Analysts, Inc., provides a comprehensive review of industry overview, product overview, product introductions/innovations, profiles of major players, and recent industry activity. The report analyzes market data and analytics in terms of value sales for regions including the US, Europe, and Rest of World.

For more details about this comprehensive market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website